Clinical Trial Update: Safety of SP-420 in the Treatment of Transfusional Iron Overload [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety of SP-420 for transfusional iron overload has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Transfusional Iron Overload

Drugs mentioned

• SP-420

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Iron Overload | Phase 1 | Status: TERMINATED